B. Myones

Enhancement of protein S anticoagulant function by beta2-glycoprotein I, a major target antigen of antiphospholipid antibodies: beta2-glycoprotein I interferes with binding of protein S to its plasma inhibitor, C4b-binding protein.

J. Merrill, R. Lahita, Hong Wei Zhang, 1999, Thrombosis and haemostasis.

Fequency of antibodies to the cholesterol transport protein apolipoprotein A1 in patients with SLE

J. Merrill, R. Lahita, C. Shen, 1998, Lupus.

Neurocognitive deficits and neuroimaging abnormalities are prevalent in children with lupus: clinical and research experiences at a US pediatric institution

E. Muscal, B. Myones, J. Hunter, 2010, Lupus.

Catch-up growth during tocilizumab therapy for systemic juvenile idiopathic arthritis: 2-year data from a phase 3 clinical trial

J. Frane, T. Lipman, A. Martini, 2014 .

PReS-FINAL-2140: Neutropenia with Tocilizumab (TCZ) treatment is not associated with increased infection risk in patients with systemic juvenile idiopathic arthritis (SJIA)

K. Minden, A. Martini, R. Burgos-Vargas, 2013, Pediatric Rheumatology.